乳腺癌中PTEN信号通路和miRNA的相关性
Mahya Mohammadi1, Ahmad Fazilat2, Alireza Soleimani Mamalo3
1Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Molecular biology reports
|January 28, 2024
概括
微RNAs (miRNAs) 调节乳腺癌 (BC) 中的酸酶和张素同类物 (PTEN). 了解这些miRNA-PTEN相互作用对于开发新的BC治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌 (BC) 是女性癌症死亡的主要原因,受遗传和环境因素的影响.
- 信号通路对BC进展和预防至关重要;PTEN抑制PI3K/Akt/mTOR通路,是一种瘤促进物.
- 微RNAs (miRNAs),小型非编码RNAs,在转录后调节基因表达,并与癌症有关.
研究的目的:
- 调查miRNAs在乳腺癌中调节PTEN功能中的作用.
- 阐明miRNAs在BC中PTEN信号传递的背景下精确的机制和功能.
主要方法:
- 这项研究的重点是识别和表征调节乳腺癌细胞中PTEN活性的miRNA.
- 调查miRNA介导的PTEN调节对癌症关键特征,如亡和扩散的影响.
主要成果:
- miRNAs可以作为PTEN的上游调解者,在BC中增强或抑制其瘤抑制功能.
- 通过特定的miRNA抑制PTEN信号传递可能导致BC细胞对化疗的敏感性降低.
结论:
- 在乳腺癌中,miRNA-PTEN相互作用是重要的调节轴.
- 对这些相互作用的进一步研究可能会揭示改善BC治疗结果的新疗法标.
相关概念视频
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


